Go Pro

Empowered Funds LLC Buys New Holdings in Palomar Holdings, Inc. $PLMR

Palomar logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Empowered Funds LLC acquired 195,118 Palomar shares worth approximately $23.3 million, giving it a 0.74% stake. Institutional investors collectively own 90.25% of the company.
  • Palomar reported quarterly EPS of $2.31, beating estimates by $0.14, while revenue rose 59.7% year over year. Analysts expect $8.90 in full-year EPS.
  • Analyst sentiment remains positive, with a consensus “Moderate Buy” rating and an average price target of $162.50 versus the stock’s reported $143.16 price. Meanwhile, insiders sold 20,843 shares worth $2.71 million over the past 90 days.
  • Five stocks to consider instead of Palomar.

Empowered Funds LLC bought a new position in Palomar Holdings, Inc. (NASDAQ:PLMR - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 195,118 shares of the company's stock, valued at approximately $23,317,000. Empowered Funds LLC owned 0.74% of Palomar at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Geneos Wealth Management Inc. acquired a new position in shares of Palomar in the 4th quarter valued at $32,000. Kestra Advisory Services LLC bought a new position in shares of Palomar during the 4th quarter worth about $33,000. Rockefeller Capital Management L.P. boosted its position in shares of Palomar by 81.5% during the 4th quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company's stock valued at $40,000 after acquiring an additional 132 shares in the last quarter. Parallel Advisors LLC boosted its position in shares of Palomar by 638.3% during the 1st quarter. Parallel Advisors LLC now owns 443 shares of the company's stock valued at $53,000 after acquiring an additional 383 shares in the last quarter. Finally, Frazier Financial Advisors LLC bought a new stake in Palomar in the fourth quarter valued at about $54,000. Institutional investors and hedge funds own 90.25% of the company's stock.

Insider Activity

In related news, CEO Mac Armstrong sold 3,500 shares of Palomar stock in a transaction dated Tuesday, July 21st. The stock was sold at an average price of $137.26, for a total value of $480,410.00. Following the completion of the transaction, the chief executive officer directly owned 325,888 shares of the company's stock, valued at $44,731,386.88. The trade was a 1.06% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Jon Christianson sold 3,000 shares of the company's stock in a transaction dated Monday, July 20th. The stock was sold at an average price of $139.50, for a total transaction of $418,500.00. Following the transaction, the president owned 66,478 shares in the company, valued at approximately $9,273,681. This trade represents a 4.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 20,843 shares of company stock worth $2,711,683. 3.70% of the stock is owned by corporate insiders.

Palomar Trading Up 1.7%

PLMR stock opened at $143.16 on Wednesday. The business has a fifty day moving average price of $122.94 and a 200 day moving average price of $123.31. Palomar Holdings, Inc. has a fifty-two week low of $100.81 and a fifty-two week high of $147.62. The stock has a market capitalization of $3.79 billion, a price-to-earnings ratio of 19.94 and a beta of 0.41. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.49 and a quick ratio of 0.49.

Palomar (NASDAQ:PLMR - Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $2.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.17 by $0.14. The firm had revenue of $278.94 million during the quarter, compared to the consensus estimate of $557.79 million. Palomar had a return on equity of 22.62% and a net margin of 20.11%.The business's revenue for the quarter was up 59.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.87 EPS. Analysts expect that Palomar Holdings, Inc. will post 8.9 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on PLMR. Keefe, Bruyette & Woods increased their price target on shares of Palomar from $162.00 to $166.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 8th. Evercore set a $152.00 price objective on Palomar in a report on Friday, July 10th. JPMorgan Chase & Co. upped their price objective on Palomar from $150.00 to $167.00 and gave the company an "overweight" rating in a research note on Monday, July 20th. Weiss Ratings upgraded Palomar from a "hold (c)" rating to a "hold (c+)" rating in a research report on Thursday, June 18th. Finally, Zacks Research cut Palomar from a "strong-buy" rating to a "hold" rating in a research report on Friday, May 15th. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $162.50.

View Our Latest Analysis on Palomar

Palomar Company Profile

(Free Report)

Palomar Holdings, Inc NASDAQ: PLMR is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.

See Also

Institutional Ownership by Quarter for Palomar (NASDAQ:PLMR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Palomar Right Now?

Before you consider Palomar, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Palomar wasn't on the list.

While Palomar currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines